Sanofi and GSK initiate global Phase 3 clinical efficacy study of the COVID-19 vaccine candidate.
PARIS and LONDON – May 27, 2021 –Today, Sanofi and GSK started enrollment in their Phase 3 clinical study to ...
ADVERTISEMENT
